FDA Opens Applications for Pilot Program to Accelerate Drug Approval Timelines

Source Summary

The FDA is accepting applications for a new pilot program aimed at reducing drug approval timelines. The initiative is designed to help the United States remain competitive with countries including China and Australia in pharmaceutical development.

Why it matters

Faster drug approval timelines could enable U.S. pharmaceutical companies to bring treatments to market more quickly and maintain competitive advantage against international rivals.